102 related articles for article (PubMed ID: 32657024)
1. Effective Oral Administration of an Antitumorigenic Nanoformulated Titanium Complex.
Nahari G; Braitbard O; Larush L; Hochman J; Tshuva EY
ChemMedChem; 2021 Jan; 16(1):108-112. PubMed ID: 32657024
[TBL] [Abstract][Full Text] [Related]
2. In Vivo Anticancer Activity of a Nontoxic Inert Phenolato Titanium Complex: High Efficacy on Solid Tumors Alone and Combined with Platinum Drugs.
Ganot N; Briaitbard O; Gammal A; Tam J; Hochman J; Tshuva EY
ChemMedChem; 2018 Nov; 13(21):2290-2296. PubMed ID: 30203598
[TBL] [Abstract][Full Text] [Related]
3. Highly Stable Tetra-Phenolato Titanium(IV) Agent Formulated into Nanoparticles Demonstrates Anti-Tumoral Activity and Selectivity.
Meker S; Braitbard O; Margulis-Goshen K; Magdassi S; Hochman J; Tshuva EY
Molecules; 2015 Oct; 20(10):18526-38. PubMed ID: 26473816
[TBL] [Abstract][Full Text] [Related]
4. Anti-proliferative activity of nano-formulated phenolato titanium(IV) complexes against cancer cells.
Meker S; Margulis-Goshen K; Weiss E; Braitbard O; Hochman J; Magdassi S; Tshuva EY
ChemMedChem; 2014 Jun; 9(6):1294-8. PubMed ID: 24677761
[TBL] [Abstract][Full Text] [Related]
5. Phenolato Ti(IV) hexacoordinate complexes for anticancer chemotherapy: enhancement of solubility, hydrolytic stability, and cytotoxicity.
Taha M; Tshuva EY
Dalton Trans; 2023 Jun; 52(22):7664-7672. PubMed ID: 37199994
[TBL] [Abstract][Full Text] [Related]
6. Binding of the anticancer Ti(IV) complex phenolaTi to serum proteins: Thermodynamic and kinetic aspects.
Shpilt Z; Tshuva EY
J Inorg Biochem; 2022 Jul; 232():111817. PubMed ID: 35421765
[TBL] [Abstract][Full Text] [Related]
7. High antitumor activity of highly resistant salan-titanium(IV) complexes in nanoparticles: an identified active species.
Meker S; Margulis-Goshen K; Weiss E; Magdassi S; Tshuva EY
Angew Chem Int Ed Engl; 2012 Oct; 51(42):10515-7. PubMed ID: 22961758
[TBL] [Abstract][Full Text] [Related]
8. From medium to endoplasmic reticulum: Tracing anticancer phenolato titanium(IV) complex by
Nahari G; Hoffman RE; Tshuva EY
J Inorg Biochem; 2021 Aug; 221():111492. PubMed ID: 34051630
[TBL] [Abstract][Full Text] [Related]
9. Curcumin-polymeric nanoparticles against colon-26 tumor-bearing mice: cytotoxicity, pharmacokinetic and anticancer efficacy studies.
Chaurasia S; Chaubey P; Patel RR; Kumar N; Mishra B
Drug Dev Ind Pharm; 2016; 42(5):694-700. PubMed ID: 26165247
[TBL] [Abstract][Full Text] [Related]
10. Deciphering the molecular mechanism and apoptosis underlying the in-vitro and in-vivo chemotherapeutic efficacy of vanadium luteolin complex in colon cancer.
Roy S; Chakraborty T
Cell Biochem Funct; 2018 Apr; 36(3):116-128. PubMed ID: 29574863
[TBL] [Abstract][Full Text] [Related]
11. Antitumor activity of 2-chloro-9-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl) adenine, a novel deoxyadenosine analog, against human colon tumor xenografts by oral administration.
Takahashi T; Kanazawa J; Akinaga S; Tamaoki T; Okabe M
Cancer Chemother Pharmacol; 1999; 43(3):233-40. PubMed ID: 9923554
[TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo characterization of XR11576, a novel, orally active, dual inhibitor of topoisomerase I and II.
Mistry P; Stewart AJ; Dangerfield W; Baker M; Liddle C; Bootle D; Kofler B; Laurie D; Denny WA; Baguley B; Charlton PA
Anticancer Drugs; 2002 Jan; 13(1):15-28. PubMed ID: 11914637
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and in vivo anticancer evaluation of poly(organo)phosphazene-based metallodrug conjugates.
Hackl CM; Schoenhacker-Alte B; Klose MHM; Henke H; Legina MS; Jakupec MA; Berger W; Keppler BK; Brüggemann O; Teasdale I; Heffeter P; Kandioller W
Dalton Trans; 2017 Sep; 46(36):12114-12124. PubMed ID: 28862707
[TBL] [Abstract][Full Text] [Related]
14. Heteroleptic titanium(IV) catecholato/piperazine systems and their anti-cancer properties.
Hancock SL; Gati R; Mahon MF; Tshuva EY; Jones MD
Dalton Trans; 2014 Jan; 43(3):1380-5. PubMed ID: 24201896
[TBL] [Abstract][Full Text] [Related]
15. [
Kim SY; Jung JH; Lee HJ; Soh H; Lee SJ; Oh SJ; Chae SY; Lee JH; Lee SJ; Hong YS; Kim TW; Moon DH
Cancer Res; 2017 Dec; 77(24):7120-7130. PubMed ID: 29055019
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo anticancer activity of a novel puerarin nanosuspension against colon cancer, with high efficacy and low toxicity.
Wang Y; Ma Y; Zheng Y; Song J; Yang X; Bi C; Zhang D; Zhang Q
Int J Pharm; 2013 Jan; 441(1-2):728-35. PubMed ID: 23089583
[TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo evaluation of organometallic gold(I) derivatives as anticancer agents.
García-Moreno E; Tomás A; Atrián-Blasco E; Gascón S; Romanos E; Rodriguez-Yoldi MJ; Cerrada E; Laguna M
Dalton Trans; 2016 Feb; 45(6):2462-75. PubMed ID: 26469679
[TBL] [Abstract][Full Text] [Related]
18. Enhanced absorption, and efficacy of oral self-assembled paclitaxel nanocochleates in multi-drug resistant colon cancer.
Shanmugam T; Joshi N; Ahamad N; Deshmukh A; Banerjee R
Int J Pharm; 2020 Aug; 586():119482. PubMed ID: 32492505
[TBL] [Abstract][Full Text] [Related]
19. Titanium Tackles the Endoplasmic Reticulum: A First Genomic Study on a Titanium Anticancer Metallodrug.
Miller M; Mellul A; Braun M; Sherill-Rofe D; Cohen E; Shpilt Z; Unterman I; Braitbard O; Hochman J; Tshuva EY; Tabach Y
iScience; 2020 Jul; 23(7):101262. PubMed ID: 32585595
[TBL] [Abstract][Full Text] [Related]
20. Specific Design of Titanium(IV) Phenolato Chelates Yields Stable and Accessible, Effective and Selective Anticancer Agents.
Meker S; Braitbard O; Hall MD; Hochman J; Tshuva EY
Chemistry; 2016 Jul; 22(29):9986-95. PubMed ID: 27320784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
